期刊文献+

关节内注射富血小板血浆与玻璃酸钠治疗膝关节骨关节炎的对比研究 被引量:12

A Comparative Study of Platelet-rich Plasma and Hyaluronic Acid Intra-articular Injection for Knee Osteoarthritics
下载PDF
导出
摘要 目的比较富血小板血浆(platelet-rich plasma,PRP)与玻璃酸钠(hyaluronic acid sodium,HA)治疗膝关节骨关节炎(knee osteoarthritis,KOA)的近期疗效。方法 2013年3月~2014年1月,将60例KOA按就诊顺序依次分至A、B、C组,每组20例。A组膝关节内注射自体PRP 5 ml,B组膝关节内注射HA 2 ml,C组膝关节内先注射PRP 5 ml,10 min后注射HA 2ml。每周一次,连续5周。治疗结束后4周采用Lysholm膝关节评分系统进行评价。结果 A组、C组各1例注射PRP后出现短暂膝关节炎症反跳,其余患者均未出现并发症。3组治疗后4周Lysholm膝关节评分较治疗前均有明显提高(A组42.3±10.5 vs.54.3±10.4,t=-7.086,P=0.000;B组41.6±10.0 vs.54.2±9.1,t=-5.450,P=0.000;C组41.8±10.4 vs.66.8±7.2,t=-12.887,P=0.000),且C组明显高于A、B组(F=12.982,P=0.000)。C组有效率(60%,12/20)明显高于A组(20%,4/20)和B组(20%,4/20)(χ2=9.600,P=0.008)。治疗前后血常规和肝、肾功能均未出现异常。结论膝关节腔注射PRP联合HA可以迅速控制疼痛并改善患者膝关节功能,具有显著的近期疗效,是治疗KOA的一种安全有效的方法,长期疗效有待继续观察。 Objective To compare the curative effects between platelet-rich plasma (PRP) and hyaluronic acid sodium (HA) intra-artieular injection for the treatment of knee osteoarthritis (KOA). Methods From March 2013 to January 2014, 60 cases of KOA were divided into A, B, C groups according to admission sequence, with 20 cases in each group. The Group A was given knee joint injection of PRP 5 ml, Group B was given knee joint injection of HA 2 ml, and Group C received knee joint injection of PRP 5 ml and HA 2 ml at 10 min afterwards, once a week for five weeks. Four weeks after treatment, we evaluated the treatment effect with the Lysholm knee score system. Results One patient in the group A and the group C respectively showed serious and transient inflammation after the injection of PRP. The rest of the all patients had no complications. After treatment, the Lysholm knee scores were obviously improved as compared to before treatment in all the three groups ( Group A: 42.3 ± 10.5 vs. 54.3 ± 10.4, t = -7.086, P=0.000; Group B. 41.6±10.0 vs. 54.2 ±9.1, t= -5.450, P=0.000; Group C: 41.8 ±10.4 vs. 66.8 ±7.2, t = - 12. 887, P = 0. 000). The scores in the Group C were significantly higher than those in the Group A and the Group B ( F = 12. 982, P =0.000). The effective rate of the Group C (60% , 12/20) was significantly higher than that in the Group A (20% , 4/20) and Group B (20% , 4/20) (X2 = 9. 600, P = 0. 008 ). Routine blood and liver and renal functions were normal before and after treatment. Conclusions Knee joint injection of PRP and HA can quickly control the pain and improve patients' joint functions. This treatment has significant short-term effects, being a safe and effective method for the treatment of KOA. However, the long-term efficacy requires further investigations.
出处 《中国微创外科杂志》 CSCD 北大核心 2015年第8期676-680,共5页 Chinese Journal of Minimally Invasive Surgery
基金 南京医科大学科技发展基金(2013njmu149)
关键词 富血小板血浆 玻璃酸钠 膝关节 骨关节炎 临床疗效 Platelet-rich plasma Hyaluronie acid sodium Knee Osteoarthritis Clinical curative effect
  • 相关文献

参考文献19

  • 1Kellgren JH, Lawrence JS. Radioiogical assessment of osteoarthrosis. AnnRheum Dis, 1963 ,22: 237 - 255.
  • 2Goldring MB, Goldring SR. Osteoarthritis. J Cell PhysioI, 2007,213 ( 3 ) : 626 - 634.
  • 3Prochazkova M ,Zanvit P, DoleoaI T, et al. Increased gene expression and production of spinal cyclooxygenase 1 and 2 during experimental osteoarthritis pain. Physiol Res ,2009 ,58(3) :419 -425.
  • 4Colen S, van den Bekerom MP, Mulier M, et al. Hyalurenic acid in the treatment of knee osteoarthritis: a systematic review and metaanalysis with emphasis on the efficacy of different products. Bio Drags,2012,26(4) :257 -268.
  • 5Pecchi E, Priam S, Mladenovic Z, et al. A potential role of chondreitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E2 and matrix metalloproteinases synthesis in interleukin-l B-stimulated osteoblasts. Osteoarthritis Cartilage ,2012, 20(2) :127 -135.
  • 6Woodell-May J, Matuska A, Oyster M, et al. Autologous protein solution inhibits MMP-13 production by IL-113 and TNFac-stimulated human articular chondrocytes. J Orthop Res, 2011 .29 (9) : 1320 - 1326.
  • 7Haas S, Strauh RH. Disruption of rllythms of molecular clocks in primary synovial fihrublasts of patients with osteoarthritis and rheumatoid arthritis, role of IL-l I3/TNF. Arthritis Res Ther,2012, 14(3) :RI22.
  • 8Foster TE, Puskas BL, Mandelbaum BR, et al. Platelet-rich plasma: from hasic science to clinical applications. Am J Sports Med, 2009, 37( 11) :2259 -2272.
  • 9Dohan Ehrenfest DM, Rasmusson L, AlbrektssonT. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol, 2009,27(3) :158 -167.
  • 10Wroblewski AP, MejiaHA, Wright VJ, et al. Application of plateletrich plasma to enhance tissue repair. Oper Tech Orthop, 2010,20 (2) :98 -105.

二级参考文献61

  • 1袁霆,张长青.骨组织及软组织修复作用中富血小板血浆的制作及其原理[J].中国临床康复,2004,8(35):7939-7941. 被引量:83
  • 2段小军,杨柳,李起鸿.骨再生与血管生成协同作用的分子机制[J].临床骨科杂志,2005,8(1):88-91. 被引量:11
  • 3尹崑,卫小春.关节液中多糖含量与关节软骨损伤的关系[J].实用骨科杂志,2006,12(3):216-219. 被引量:9
  • 4胥少汀,葛宝丰,等.实用骨科学.北京:人民卫生出版社,2009:656.
  • 5Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum, 2000, 43: 1905-1915.
  • 6Schnitzer TJ, American College of Rheumatology. Update of ACR guidelines for osteoarthritis: role of the coxibs. J Pain Symptom Manage, 2002, 23(4 Suppl): S24-34.
  • 7Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅱ. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum, 1995, 38:1541-1546.
  • 8Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅰ. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum, 1995, 38: 1535-1540.
  • 9Simon LS, Lipman AG, Jacox AK, eds. Pain in osteoarthritis, rheumatoid arthritis and juvenile chronic arthritis. 2nd ed. Glenview (IL): American Pain Society (APS), 2002. 179.
  • 10Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2007, 66: 377-388.

共引文献1969

同被引文献98

引证文献12

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部